Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

555.00 -14.64 (-2.57%)
Streaming Delayed Price Updated: 10:22 AM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
This Is What Whales Are Betting On Eli Lilly
Via Benzinga
3 Reasons to Buy Eli Lilly Stock
Shares of the giant drugmaker aren't far off their 52-week high. 
Via The Motley Fool
Your Mid-August Market Update: Selling And Scanning
Stock indexes slid 1% today with bonds closing weaker, down at 2023 lows as interest rates traded up to highs in 2023. 
Via Talk Markets
Topics Bonds
Exposures Debt Markets
Eli Lilly & Company (LLY) Remains Supported In Bullish sequence
Via Talk Markets
Amazon's Boon for Diabetes Patients - Streamlining Pharmacy Discounts
Amazon.Com Inc's (NASDAQ: AMZN) online pharmacy launched a new initiativ 
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
Via Benzinga
Check Out What Whales Are Doing With LLY
Via Benzinga
Why Shares of Eli Lilly Jumped This Week
The company's second-quarter report showed a big revenue surge. 
Via The Motley Fool
How The Weight-Loss Frenzy Drove Cardinal Health Into A Breakout — Briefly
The company helps deliver weight-loss and other drugs to pharmacies, hospitals and physicians. 
Via Investor's Business Daily
Is Tesla's CFO Change Something to Worry About?
We also talk about Eli Lilly hitting an all-time high, Burger King driving sales growth, and Zoom's work-from-home policy. 
Via The Motley Fool
Pharma ETFs in Focus Post Q2 Earnings
Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth. 
Via Talk Markets
Topics ETFs
5 ETFs Responding To PPI Surge And Consumer Sentiment Dip On Friday
Via Benzinga
Topics ETFs
Expert Ratings for Eli Lilly
Via Benzinga
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
Eli Lilly Stock Is A ‘Buy’ After Its Blockbuster Q2
Eli Lilly stock has already gained about 45% year-to-date. 
Via Talk Markets
Market Rally On The Ropes, AI Stocks Tumble: Weekly Review
The Nasdaq fell below its 50-day moving average. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ex-Fund Manager Regrets Missing The Boat On A Stock Which Rallied 16% This Week: 'I Should Have Followed My Instincts'
Whitney Tilson recalled his comments in late-2022 about 'miraculous' weight-loss drugs and said he regretted not buying Eli Lilly stock then. 
Via Benzinga
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
Via Benzinga
3 Growth Stocks to Sell in August Before They Crash and Burn
Smart investors are proceeding cautiously with these securities either suffering a pullback or in danger of one. 
Via InvestorPlace
65% Profit On Eli Lilly — 20% Reduction In Heart Attacks And Strokes With Weight Loss Drug — Raising The Target
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Via Benzinga
Eli Lilly Analysts Bump Up Forecasts On Q2 Print: 'Beyond Mounjaro, Alzheimer's Franchise Remains A Key Pillar To Future Growth'
Shares of Eli Lilly And Co (NYSE: LLY) Tuesday spiked, after the company reported strong second-quarter results. 
Via Benzinga
After This Pharma Stock Surges To Record High, Cramer Says It's 'Going Higher Still'
Eli Lilly reported a beat-and-raise Q2 on Tuesday and its stock moving into record territory and Cramer thinks there is more upside to it. 
Via Benzinga
Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy?
Lilly shares surged 15% in one day to a record high. Here's what you should know. 
Via Investor's Business Daily
CBOE Volatility Index Increases Ahead Of Inflation Data
The S&P 500 settled lower on Tuesday, after credit rating agency Moody's downgraded 10 small- to mid-sized lenders. The S&P 500 Banks index has lost 2.5% year-to-date, versus a 17.2% surge recorded by... 
Via Benzinga
Earnings Surprises And Inflation Still In Play: Your Midweek Market Update
We had a surprise 15% gain in Eli Lilly on earnings today and we're gearing up for Disney's earnings tomorrow. 
Via Talk Markets
Wegovy, Ozempic Could Save 139,400 Lives In US Each Year; Novo Nordisk Heart Attack Research Reveals New Benefits
Via Benzinga
Eli Lilly (LLY) Stock Just Reached a New All-Time High
Pharma giant Eli Lilly saw LLY stock reach record heights as the company posted strong Q2 results, undergirded by a key diabetes drug. 
Via InvestorPlace
Moody's Downgrades Hits Banks, But Health Care Glows As Lilly, Novo Nordisk Boosted By Earnings, Data
(Tuesday market open) Several months after the opening salvo, regional banks came back into focus Tuesday morning after Moody’s cut ratings on several of them and warned that more downgrades might be... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.